Learn from Nicole L. Stout and 850+ other industry-leading experts.
Browse PlansNicole L. Stout
DPT, CLT-LANA, FAPTA
Dr. Nicole L. Stout is a research assistant professor in the School of Medicine, Department of Hematology/Oncology at West Virginia University Cancer Institute and with the School of Public Health, Department of Health Policy, Management, and Leadership. She also serves as the associate director of the WVU Cancer Institute's Survivorship Program, where she coordinates the survivorship research agenda and supportive care infrastructure development between the cancer center and community. Dr. Stout's research focuses on the implementation of prospective, risk-stratified functional assessment and symptom management strategies in cancer care delivery and on studying community outreach and engagement strategies with rural primary care providers to enable community-based survivorship care. Dr. Stout is the co-chair of the Alliance Clinical Trials Network Rural Health Working Group and a steering committee member with the Appalachian Community Cancer Alliance, and she serves on the board of directors for the West Virginia Oncology Society.
Dr. Stout is an internationally recognized expert and leader in the field of cancer rehabilitation and survivorship care. Her work and research have been foundational to developing the prospective surveillance model for morbidity management in cancer care. She has given over 300 lectures nationally and internationally, has authored and coauthored over 90 peer-review and invited publications and several book chapters, and is the coauthor of the book 100 Questions and Answers about Lymphedema. She has led expert consensus initiatives through the American Cancer Society, the World Health Organization, and the National Institutes of Health and has served as a content expert in cancer survivorship and rehabilitation for media outlets across the US.
She received her Bachelor of Science degree from Slippery Rock University in Pennsylvania, a Masters of Physical Therapy degree from Chatham University in Pittsburgh, Pennsylvania, and her Doctor of Physical Therapy from MGH Institute of Health Professions in Boston, Massachusetts. She also has a postgraduate certificate in Health Policy from the George Washington University School of Public Health.
Courses with Nicole L. Stout
Browse Course CatalogRehabilitation Across the Cancer Care Continuum (Recorded Webinar)
Presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Rehabilitation Across the Cancer Care Continuum (Recorded Webinar)
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 160 Minutes; Learning Assessment Time: 19 Minutes
This course is a recording of a previously hosted live webinar event. Polling and question submission features are not available for this recording. Format and structure may differ from standard MedBridge courses.
Cancer care occurs across a protracted timeline, commonly over at least a year. Individuals with advanced cancer may be on active treatment for the remainder of their lives. Rehabilitation services should be incorporated into cancer care from the point of a cancer diagnosis and can provide effective interventions aimed at improving and restoring function throughout the duration of the individual's life span. This webinar will discuss the evidence base for rehabilitation interventions across the cancer care continuum. We will discuss the four domains of cancer rehabilitation--preventive, restorative, supportive, and palliative--and will emphasize the importance of prospective screening for functional morbidity and early intervention for cancer treatment-related impairments throughout this care continuum.
This course is a recording of a previously hosted live webinar event. Polling and question submission features are not available for this recording. Format and structure may differ from standard MedBridge courses.
Cancer care occurs across a protracted timeline, commonly over at least a year. Individuals with advanced cancer may be on active treatment for the remainder of their lives. Rehabilitation services should be incorporated into cancer care from the point of a cancer diagnosis and can provide effective interventions aimed at improving and restoring function throughout the duration of the individual's life span. This webinar will discuss the evidence base for rehabilitation interventions across the cancer care continuum. We will discuss the four domains of cancer rehabilitation--preventive, restorative, supportive, and palliative--and will emphasize the importance of prospective screening for functional morbidity and early intervention for cancer treatment-related impairments throughout this care continuum.
Assessment and Management of Older Adults With Cancer
Presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Assessment and Management of Older Adults With Cancer
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 47 Minutes; Learning Assessment Time: 46 Minutes
Older adults with cancer are a large and growing segment of our population. Geriatric oncology is a medical discipline that has emerged with evidence for specific assessment tools and interventions that are tailored to the needs of older adults. Rehabilitation providers should be aware of the specific guidelines and recommendations that support care interventions for older adults with cancer. This course will describe the unique needs of older adults with cancer and outline the specific assessment tools and evidence-based rehabilitation interventions for this population. The course will review current oncology guidelines for older adults with cancer and identify the relevant recommendations that impact the rehabilitation plan of care.
Older adults with cancer are a large and growing segment of our population. Geriatric oncology is a medical discipline that has emerged with evidence for specific assessment tools and interventions that are tailored to the needs of older adults. Rehabilitation providers should be aware of the specific guidelines and recommendations that support care interventions for older adults with cancer. This course will describe the unique needs of older adults with cancer and outline the specific assessment tools and evidence-based rehabilitation interventions for this population. The course will review current oncology guidelines for older adults with cancer and identify the relevant recommendations that impact the rehabilitation plan of care.
Cancer Survivorship: Late Effects and Advanced Disease in Older Adults
Presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Cancer Survivorship: Late Effects and Advanced Disease in Older Adults
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 48 Minutes; Learning Assessment Time: 43 Minutes
Cancer-treatment-related side effects often have multisystem impact that negatively impacts function. Many side effects that occur during cancer treatment may persist and continue to cause impairment and functional morbidity after treatment is completed. Further, some side effects of treatment may not present until years after treatment is complete. This course takes a multisystem approach to understanding the physical, cognitive, and psychosocial late effects associated with cancer treatment. It also explores advanced cancer treatment, as the continuum of care for individuals with advanced cancer may be much longer, inciting a greater burden of side effects. The course covers assessment for common late effects, evidence-based interventions, and safety considerations.
Cancer-treatment-related side effects often have multisystem impact that negatively impacts function. Many side effects that occur during cancer treatment may persist and continue to cause impairment and functional morbidity after treatment is completed. Further, some side effects of treatment may not present until years after treatment is complete. This course takes a multisystem approach to understanding the physical, cognitive, and psychosocial late effects associated with cancer treatment. It also explores advanced cancer treatment, as the continuum of care for individuals with advanced cancer may be much longer, inciting a greater burden of side effects. The course covers assessment for common late effects, evidence-based interventions, and safety considerations.
Chemotherapy and Its Impact on Function
Presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Chemotherapy and Its Impact on Function
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 100 Minutes; Learning Assessment Time: 57 Minutes
Chemotherapy is prevalent in cancer care and involves the systemic delivery of toxic agents to reduce the viability of cancer cells in the body. The effects of chemotherapy are therefore broadly systemic, inciting negative impact across multiple body systems during cancer treatment, but can also lead to long-term, late effects that contribute to chronic functional limitations and disability. Due to the late effects of treatment, the functional impact is sometimes delayed for years following treatment and warrants consideration by rehabilitation providers planning care for individuals with even a long-term history of cancer treatment. This course will review commonly used chemotherapeutic agents, their short- and long-term side effects. It will also provide specific insight on the adverse effects across body systems, including: neurotoxcity, cardiotoxicity, cognitive changes, and cancer-related fatigue. Strategies for screening and assessment, as well as rehabilitation interventions, will be reviewed.
Chemotherapy is prevalent in cancer care and involves the systemic delivery of toxic agents to reduce the viability of cancer cells in the body. The effects of chemotherapy are therefore broadly systemic, inciting negative impact across multiple body systems during cancer treatment, but can also lead to long-term, late effects that contribute to chronic functional limitations and disability. Due to the late effects of treatment, the functional impact is sometimes delayed for years following treatment and warrants consideration by rehabilitation providers planning care for individuals with even a long-term history of cancer treatment. This course will review commonly used chemotherapeutic agents, their short- and long-term side effects. It will also provide specific insight on the adverse effects across body systems, including: neurotoxcity, cardiotoxicity, cognitive changes, and cancer-related fatigue. Strategies for screening and assessment, as well as rehabilitation interventions, will be reviewed.
Exercise and Cancer: Indications, Safety, and Evidence-Based Interventions
Presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Exercise and Cancer: Indications, Safety, and Evidence-Based Interventions
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 68 Minutes; Learning Assessment Time: 42 Minutes
The physiological effects of exercise are well-accepted as beneficial to the population of cancer survivors. Although a robust body of evidence demonstrates the safety and efficacy of exercise during and after cancer treatment, exercise has struggled to achieve prominent attention alongside disease-mitigating cancer therapies. This course will review indications for exercise at any stage of cancer and at any point along the continuum of cancer care. Individualized exercise prescription for medically complex patients, regular reassessment, and modifications to treatment planning will be reviewed in order to optimize care planning to adequately impact function through exercise prescription.
The physiological effects of exercise are well-accepted as beneficial to the population of cancer survivors. Although a robust body of evidence demonstrates the safety and efficacy of exercise during and after cancer treatment, exercise has struggled to achieve prominent attention alongside disease-mitigating cancer therapies. This course will review indications for exercise at any stage of cancer and at any point along the continuum of cancer care. Individualized exercise prescription for medically complex patients, regular reassessment, and modifications to treatment planning will be reviewed in order to optimize care planning to adequately impact function through exercise prescription.
Hormonal Adjuvant Therapy and Its Impact on Function
Presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Hormonal Adjuvant Therapy and Its Impact on Function
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 66 Minutes; Learning Assessment Time: 29 Minutes
The most prevalent cancers in the United States today, breast and prostate, are commonly treated with a long-term regimen of hormonal drug agents proven to reduce the growth of cancer cells and reduce the risk of disease recurrence. These drug agents also incite significant interactions systemically that contribute to a high rate of functional impairment including bone density loss, pain, increased adiposity, and reduced lean mass in these patients. Guidelines for hormonal therapies recommend treatment for 3-5 years post completion of cancer treatment. The protracted timeline for treatment and the aggregate burden of these side effects increase the risk for long-term disability and frailty in cancer survivors and warrant specific rehabilitative interventions to mitigate their impact.
The most prevalent cancers in the United States today, breast and prostate, are commonly treated with a long-term regimen of hormonal drug agents proven to reduce the growth of cancer cells and reduce the risk of disease recurrence. These drug agents also incite significant interactions systemically that contribute to a high rate of functional impairment including bone density loss, pain, increased adiposity, and reduced lean mass in these patients. Guidelines for hormonal therapies recommend treatment for 3-5 years post completion of cancer treatment. The protracted timeline for treatment and the aggregate burden of these side effects increase the risk for long-term disability and frailty in cancer survivors and warrant specific rehabilitative interventions to mitigate their impact.
Start any course for free!
Get access to the first chapter of all 2600+ courses when you create a free account.
Sign Up for Free